Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

8.93
+0.01000.11%
Post-market: 8.90-0.0300-0.34%19:30 EDT
Volume:763.53K
Turnover:6.81M
Market Cap:633.21M
PE:-7.15
High:9.05
Open:8.84
Low:8.78
Close:8.92
52wk High:11.45
52wk Low:4.50
Shares:70.91M
Float Shares:67.62M
Volume Ratio:0.64
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2490
EPS(LYR):-1.5800
ROE:-24.37%
ROA:-16.41%
PB:2.47
PE(LYR):-5.65

Loading ...

Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2024

Correspondence

Form CORRESP - Correspondence
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities